Xijing Hospital Of Digestive Diseases
Clinical trials sponsored by Xijing Hospital Of Digestive Diseases, explained in plain language.
-
Can a common supplement reverse stomach cancer risk?
Disease control Not yet recruitingThis study tests whether berberine, a natural compound, can reverse gastric intestinal metaplasia—a precancerous condition in the stomach lining. Researchers will give 204 adults without H. pylori infection either berberine or a placebo daily for 6 months, checking every 4 weeks …
Phase: PHASE4 • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC
-
New camera trick could slash stomach surgery risks
Symptom relief Not yet recruitingThis study tests whether using a special imaging technique called Red Dichromatic Imaging (RDI) throughout the entire ESD procedure can reduce serious complications like bleeding and perforation, and shorten surgery time. About 640 adults with early stomach cancer or precancerous…
Phase: NA • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC